241
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon

, &
Pages 73-83 | Received 05 Feb 2010, Accepted 09 Aug 2010, Published online: 05 Oct 2010

References

  • Yang L, Chu JS, Fix JA. Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharmaceut 2002;235:1–15.
  • Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci 2003;6:33–66.
  • Prantera C, Marina R. 5-ASA in ulcerative colitis: Improving treatment compliance. World J Gastroenterol 2009;15(35):4353–4355.
  • Lee VHL, Mukherjee SK. Drug delivery: Oral colon-specific. Encyclopedia of pharmaceutical technology. 3rd ed, Vol. 2. New York: Informa Healthcare, USA Inc; 2007:1228 –1240.
  • Kumar P, Mishra B. Colon targeted drug delivery systems – an overview. Curr Drug Deliv 2008;5:186–198.
  • Casadei MA, Pitarresi G, Calabrese R, Paolicelli P, Giammona G. Biodegradable and pH-sensitive hydrogels for potential colon-specific drug delivery: Characterization and in vitro release studies. Biomacromolecules 2008;9:43–49.
  • Asghar L, Chandran S. Multiparticulate formulation approach to colon specific drug delivery: Current perspectives. J Pharm Pharmaceut Sci 2006;9(3):327–338.
  • Bodmeier R. Tableting of coated pellets. Eur J Pharmaceut Biopharmaceut 1997;43:1–8.
  • Vergote GJ, Kiekens F, Vervaet C, Remon JP. Wax beads as binder/ disintegrant agents during the compression of coated diltiazem pellets. Eur J Pharmaceut Sci 2002;17(3):145–151.
  • El-Gazayerly O, Vipaporn R, Ayres JW. Novel chewable sustained-release tablet containing Verapamil hydrochloride. Pharmaceut Develop Technol 2004;9(2):181–188.
  • Altaf SA, Hoag SW, Ayres JW. Bead compacts. I. Effect of compression on maintenance of polymer coat integrity in multilayered bead formulations. Drug Develop Industr Pharmacy 1998;24(8):737–746.
  • Palmieri GF, Wehrle P, Martelli S. Drug release from compressed Eudragit® RS 30D coated beads. Pharma Sci 1996;6(2):118–121.
  • Bechard SR, Leroux JC. Coated pelletized dosage form: Effect of compaction on drug release. Drug Develop Industr Pharmacy 1992;18(18):1927–1944.
  • Altaf SA, Hoag SW, Ayres JW. Bead compacts., II. Evaluation of rapidly disintegrating nonsegregating compressed bead formulations. Drug Develop Industr Pharmacy 1999;25(5):635–642.
  • Habib YS, Augsburger LL, Shangraw RF. Production of inert binder/ disintegrant beads: Effect of excipients on the physicomechanical properties of freeze-dried beads containing microcrystalline cellulose produced by extrusion-spheronization. Int J Pharmaceut 2002;233(1–2):67–83.
  • Bendas ER, Christensen JM, Ayres JW. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets. Drug Develop Industr Pharmacy 2010;36(4):393–404.
  • Chuong M, Ayres JW, Christensen JM. Sustained delivery of intact drug to the colon: Mesalamine formulation and temporal gastrointestinal transit analysis. Pharmaceut Develop Technol 2009;14(1):116–125.
  • USP 31; 2008: 667–669, and 2632–2633.
  • Davis SS, Hardy JG, Taylor MJ, Whalley DR, Wilson CG. The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). Int J Pharmaceut 1984;21(3):331–340.
  • Karrouta Y, Neut C, Wilsc D, Siepmann F, Deremaux L, Flamenta M, Dubreuil L, Desreumaux P, Siepmann J. Novel polymeric film coatings for colon targeting: Drug release from coated pellets. Eur J Pharmaceut Sci 2009;(37):427–433.
  • Rudolph MW, Klein S, Beckert TE, Petereit H, Dressman JB. A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. Eur J Pharmaceut Biopharmaceut 2001;(51):183–190.
  • Ragnarsson G, Johansson MOJ. Coated drug cores in multiple unit preparations, influence of particle size. Drug Develop Industr Pharmacy 1988;14(15–17):2285–2297.
  • Watanalumerd P, Christensen JM, Ayres JW. Pharmacokinetic modeling and simulation of gastrointestinal transit effects of plasma concentration of drug from mixed immediate-release and enteric-coated pellets. Pharmaceut Develop Technol 2007;12(2):193–202.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.